Saturday, 31 October 2026European Markets

ZAPTEC Stock Was Up By 9.08% Today

Loading stream...

(VIANEWS) - The Market ended the session with ZAPTEC (ZAP.OL) rising 9.08% to kr13.82 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.47% to kr1,424.98.

ZAPTEC's last close was kr12.67, 71.06% below its 52-week high of kr43.78.

About ZAPTEC

Zaptec ASA engages in the development and sale of chargers, charging systems, and services for electric car charging in Norway, Sweden, Switzerland, Denmark, Iceland, rest of Europe, and internationally. It offers Zaptec Go and Zaptec Pro alternating current walls charging station for indoor and outdoor use; Zaptec Portal, a cloud platform that monitors, balances, and optimizes the load between charging stations, while displaying real-time power usage; and Zaptec Sense for automatically adjusting the charging speed in the buildings. The company also offers accessories, including covers, charging cables, cable holders, RFID tags, and load balancers. Zaptec ASA was incorporated in 2012 and is headquartered in Stavanger, Norway.

Earnings Per Share

As for profitability, ZAPTEC has a trailing twelve months EPS of kr0.26.

PE Ratio

ZAPTEC has a trailing twelve months price to earnings ratio of 53.15. Meaning, the purchaser of the share is investing kr53.15 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.37%.

More news about ZAPTEC (ZAP.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com
ZAPTEC Stock Was Up By 9.08% Today | ViaNews EU